tiprankstipranks
Leap Therapeutics Inc (LPTX)
NASDAQ:LPTX
Holding LPTX?
Track your performance easily

Leap Therapeutics (LPTX) Income Statement

874 Followers

Leap Therapeutics Income Statement

Last quarter (Q3 2024), Leap Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Leap Therapeutics's net income was $-18.18M. See Leap Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
---$ 1.50M$ 1.50M-
Cost of Revenue
------
Gross Profit
---$ 1.50M$ 1.50M-
Operating Expense
$ 68.77M$ 85.94M$ 54.71M$ 42.93M$ 30.04M$ -33.45M
Operating Income
$ -68.77M$ -87.04M$ -56.76M$ -41.43M$ -28.54M$ -33.45M
Net Non Operating Interest Income Expense
-$ -4.03M$ -871.00K$ -41.00K$ -39.00K$ -23.00K
Other Income Expense
-$ 499.00K$ -608.00K-$ 303.00K-
Pretax Income
$ -67.77M$ -81.41M$ -54.45M$ -40.61M$ -27.52M$ -32.90M
Tax Provision
$ 708.00K-$ 147.00K$ -24.00K$ -2.00K$ -3.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -66.05M$ -81.41M$ -54.60M$ -40.59M$ -37.59M$ -33.70M
Basic EPS
$ -1.98$ -3.98$ -4.80$ -4.70$ -6.30$ -14.70
Diluted EPS
$ -1.98$ -3.98$ -4.80$ -4.70$ -6.30$ -14.70
Basic Average Shares
$ 134.33M$ 20.45M$ 11.32M$ 8.58M$ 5.93M$ 2.26M
Diluted Average Shares
$ 134.33M$ 20.45M$ 11.32M$ 8.58M$ 5.93M$ 2.26M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 68.77M$ 85.94M$ 54.71M$ 42.93M$ 30.04M$ -33.45M
Net Income From Continuing And Discontinued Operation
$ -65.82M$ -81.41M$ -54.60M$ -40.59M$ -27.51M$ -33.34M
Normalized Income
$ -65.36M$ -64.32M-$ -40.63M--
Interest Expense
------
EBIT
$ -67.00M$ -81.41M$ -54.40M$ -40.57M$ -27.48M$ -32.88M
EBITDA
$ -66.70M$ -81.40M$ -54.38M$ -40.54M$ -26.81M$ -32.83M
Currency in USD

Leap Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis